This protocol applies to patients with Brugada syndrome who present with a spontaneous type 1 Brugada ECG pattern and remain asymptomatic — specifically, with no history of syncope. The spontaneous nature of the ECG pattern, as distinct from a drug-induced finding, defines the risk context and shapes the clinical approach.
In asymptomatic patients with this ECG finding, management involves an electrophysiological evaluation aimed at risk stratification. A structured invasive testing protocol is applied to guide further decisions.
The complete protocol — including the specific testing technique, criteria used, and decision thresholds — is available in the full structured regimen below.
DOI: 10.1093/eurheartj/ehac262